ENTITY
VISEN Pharmaceuticals (2561 HK)
VISEN Pharmaceuticals (2561 HK)
8
Analysis
Health Care • China
VISEN Pharmaceuticals develops biopharmaceutical technology focused on treatments in selected endocrinology diseases. The Company provides lonapegsomatropin, navepegritide, palopegteriparatide, and other treatments. VISEN Pharmaceuticals conducts businesses in China.
morex